Holen Sie sich die Stockscreener-App
0.39
1.35%
0.0052
Handel nachbörslich:
.40
0.01
+2.56%
Schlusskurs vom Vortag:
$0.3848
Offen:
$0.3848
24-Stunden-Volumen:
177.62K
Relative Volume:
0.33
Marktkapitalisierung:
$15.38M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.67M
KGV:
-0.1262
EPS:
-3.09
Netto-Cashflow:
$-101.06M
1W Leistung:
+2.90%
1M Leistung:
-10.30%
6M Leistung:
-11.34%
1J Leistung:
-86.82%
1-Tages-Spanne:
$0.3848
$0.4122
1-Wochen-Bereich:
$0.36
$0.4122
52-Wochen-Spanne:
$0.2195
$3.67
Athira Pharma Inc Stock (ATHA) Company Profile
Firmenname
Athira Pharma Inc
Sektor
Branche
Telefon
(425) 620-8501
Adresse
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Vergleichen Sie ATHA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
0.39 | 15.18M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-19 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-09-04 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-09-04 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-09-04 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2024-08-19 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-10-17 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-06-23 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-06-23 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-23 | Herabstufung | Stifel | Buy → Hold |
| 2022-05-10 | Eingeleitet | BTIG Research | Buy |
| 2022-04-21 | Eingeleitet | Berenberg | Buy |
| 2021-12-15 | Eingeleitet | Goldman | Neutral |
| 2020-10-13 | Eingeleitet | Goldman | Buy |
| 2020-10-13 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-13 | Eingeleitet | Jefferies | Buy |
| 2020-10-13 | Eingeleitet | Stifel | Buy |
Alle ansehen
Athira Pharma Inc Aktie (ATHA) Neueste Nachrichten
Athira Pharma Inc. Testing Reversal Zone on Weekly ChartRecession Risk & Accurate Technical Buy Alerts - 선데이타임즈
Sentiment analysis tools applied to Athira Pharma Inc.July 2025 PreEarnings & Growth Focused Entry Point Reports - Newser
Analyzing Athira Pharma Inc. with risk reward ratio charts2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - Newser
Exit strategy if you’re trapped in Athira Pharma Inc.2025 Geopolitical Influence & Low Risk High Reward Ideas - Newser
What moving averages say about Athira Pharma Inc.Market Growth Summary & AI Driven Stock Movement Reports - Newser
Athira Pharma’s SWOT analysis: ALS drug developer’s stock faces pivotal moment - Investing.com
How to monitor Athira Pharma Inc. with trend dashboardsWeekly Gains Summary & Technical Entry and Exit Tips - Newser
Is Athira Pharma Inc. building a consolidation baseReal-Time Entry Signals for Top Stocks - Newser
Athira Pharma Reports Reduced Losses Amid Financial Challenges - TipRanks
Competitive Positioning of Athira Pharma Inc.: Is It Leading or LaggingPredictive Screener for Daily Trade Watch - Newser
Reversal indicators forming on Athira Pharma Inc. stockFree Consistent Profit Pattern Recognition Tools - Newser
Athira Pharma Inc. stock prediction for this weekFree Low Risk Picks for Daily Trading - Newser
Can momentum traders help lift Athira Pharma Inc.Free Risk-Adjusted Picks With Exit Strategy - Newser
Will Athira Pharma Inc. rebound enough to break evenPortfolio Positioning Strategy With Timing - Newser
Using R and stats models for Athira Pharma Inc. forecastingFree Weekly Chart Analysis With Entry Advice - Newser
Can machine learning forecast Athira Pharma Inc. recoveryInstitutional Holding Behavior Pattern Analysis - Newser
What to do if you’re stuck in Athira Pharma Inc.Free Stock Selection With High Accuracy - Newser
Using fundamentals and technicals on Athira Pharma Inc.Low Risk Strategy with Smart Entry Zones - Newser
Why Athira Pharma Inc. stock attracts strong analyst attentionFast-Growing Stock Candidates - sisain.net
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Athira (ATHA) Q2 Loss Narrows 74% - The Motley Fool
Athira (ATHA) Q2 Loss Narrows 74% - The Globe and Mail
Athira Pharma Q2 net loss narrows - MarketScreener
Athira's New ALS Drug ATH-1105 Achieves Critical Safety Milestone in Phase 1 Trial, Strategic Review Continues - Stock Titan
Can technical indicators confirm Athira Pharma Inc.’s reversalWeekly Stock Market Strategy Summary - Newser
Athira Pharma (ATHA) to Release Earnings on Thursday - Defense World
How Athira Pharma Inc. stock performs during market volatilityAI Model Forecasting Reversal and Breakout Zones - Newser
Is Athira Pharma Inc. a growth stock or a value stockOver 200% growth - Jammu Links News
Should I hold or sell Athira Pharma Inc. stock in 2025Explosive returns - Jammu Links News
What are analysts’ price targets for Athira Pharma Inc. in the next 12 monthsAchieve rapid returns with smart investment plans - Jammu Links News
Athira Pharma Inc. Stock Analysis and ForecastCapitalize on momentum-driven opportunities - Jammu Links News
What markets is PYPD expanding into Is Athira Pharma Inc. stock a good long term investment optionAchieve breakthrough profits with smart strategies - Jammu Links News
Finanzdaten der Athira Pharma Inc-Aktie (ATHA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):